High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular ResponsesCORTES, Jorge E; KANTARJIAN, Hagop M; SALVADO, August et al.Journal of clinical oncology. 2009, Vol 27, Num 28, pp 4754-4759, issn 0732-183X, 6 p.Article

Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States Medicare BeneficiariesGOLDBERG, Stuart L; ER CHEN; CORRAL, Mitra et al.Journal of clinical oncology. 2010, Vol 28, Num 17, pp 2847-2852, issn 0732-183X, 6 p.Article

Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapyBISACCIA, Emil; PALANGIO, Mark; GONZALEZ, Joselyn et al.Journal of clinical apheresis (Print). 2006, Vol 21, Num 3, pp 181-187, issn 0733-2459, 7 p.Article

A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndromeKIRSCHBAUM, Mark; GOJO, Ivana; EID, Joseph E et al.British journal of haematology. 2014, Vol 167, Num 2, pp 185-193, issn 0007-1048, 9 p.Article

Phase III, Randomized, Open-Label Study of Daily Imatinib Mesylate 400 mg Versus 800 mg in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase Using Molecular End Points: Tyrosine Kinase Inhibitor Optimization and Selectivity StudyCORTES, Jorge E; BACCARANI, Michele; MOIRAGHI, Beatriz et al.Journal of clinical oncology. 2010, Vol 28, Num 3, pp 424-430, issn 0732-183X, 7 p.Article

Association between regular molecular monitoring and tyrosine kinase inhibitor therapy adherence in chronic myelogenous leukemia in the chronic phaseGUERIN, Annie; LEI CHEN; DEA, Katherine et al.Current medical research and opinion. 2014, Vol 30, Num 7, pp 1345-1352, issn 0300-7995, 8 p.Article

Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinibGOLDBERG, Stuart L; LEI CHEN; GUERIN, Annie et al.Current medical research and opinion. 2013, Vol 29, Num 9, pp 1075-1082, issn 0300-7995, 8 p.Article

Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion needGOLDBERG, Stuart L; ER CHEN; SASANE, Medha et al.Transfusion (Philadelphia, PA). 2012, Vol 52, Num 10, pp 2131-2138, issn 0041-1132, 8 p.Article

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy. CommentaryROWE, Jacob M; HOCHHAUS, Andreas; NIEDERWIESER, Dietger et al.Blood. 2007, Vol 109, Num 6, issn 0006-4971, 2271,2303-2309 [8 p.]Article

Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphomaROBERTSON, Michael J; KAHL, Brad S; DARSTEIN, Christelle et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1741-1746, issn 0732-183X, 6 p.Article

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximabGOLDBERG, Stuart L; PECORA, Andrew L; ALTER, Robert S et al.Blood. 2002, Vol 99, Num 4, pp 1486-1488, issn 0006-4971Article